Literature DB >> 9256305

The concurrence of lupus and fibromyalgia: implications for diagnosis and management.

R Bennett1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9256305     DOI： 10.1177/096120339700600603

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  3 in total

1.  Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors:  I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

2.  Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up.

Authors:  Ina Kötter; Daniela Neuscheler; Ilhan Günaydin; Dorothee Wernet; Reinhild Klein
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

Review 3.  Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications.

Authors:  Dan Buskila; Joseph Press; Mahmoud Abu-Shakra
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.